-
In this paper, Hart and colleagues report the results of a meta-analysis of antithrombotic therapy in patients with nonvalvular atrial fibrillation (NVAF).
-
Aliskiren is a new class of drugs that directly inhibit renin and is approved in the U.S.A. for the treatment of hypertension. Valsartan is the best selling antihypertensive medication in the world.
-
This report describes a large group of patients with hypertrophic cardiomyopathy (HCM) who underwent implantable cardioverter defibrillator (ICD) implantation at 42 referral and nonreferral institutions in the United States, Europe and Australia.
-
Dalal and his colleagues describe data from the Johns Hopkins Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) registry concerning the efficacy of catheter ablation for ventricular tachycardia (VT) in this condition.
-
The increasing use of 64-slice computed tomography or MSCT is beginning to significantly impact the medical literature.
-
Patients with peripheral artery disease are at high risk for cardiovascular complications. Antiplatelet drugs are routinely prescribed for these patients, but is adding an oral anticoagulant of value?
-
-
Asymptomatic individuals with systolic left ventricular (LV) dysfunction have an increased mortality. Angiotensin converting enzymes inhibitors (ACEI) and angiotensin receptor blockers (ARB) favorably affect such patients, but little is known abut the effect of beta-blockers in this group.
-
Biomarkers such as brain natriuretic peptides (BNP) and troponin have been shown to be of diagnostic and prognostic value in patients with heart failure, but little is known abut the value of serial outpatient measurements.
-
In the latest issue of Obstetrics and Gynecology there were 3 papers, loosely tied together, that should provide important guidance to clinicians dealing with preterm labor (PTL). One article will be the source for the primary review, but the others will be folded into the comments sections.
